Literature DB >> 25974661

Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.

Yoko Kitamura1, Masaharu Yoshihara2, Masanori Ito1, Tomoyuki Boda1, Taiji Matsuo3, Takahiro Kotachi1, Shinji Tanaka3, Kazuaki Chayama1.   

Abstract

BACKGROUND AND AIM: Gastric cancer develops due to atrophic gastritis induced by Helicobacter pylori (H. pylori) infection. Serum levels of pepsinogen (PG) are known to be excellent markers for evaluating the degree of atrophic gastritis. We investigated whether chronic gastritis could be diagnosed by evaluating serum PG levels.
METHODS: A total of 4483 patients (average age, 49.7 years; 2879 men) were included in this study. Fasting serum samples were collected and anti-H. pylori antibody and PG levels were evaluated. We evaluated the endoscopic atrophy grade or histological extent of gastritis, and calculated the diagnostic capability of this serum marker.
RESULTS: A total of 4483 patients, were diagnosed as being positive (4160) or negative (323) for H. pylori-induced gastritis. In patients with H. pylori-induced gastritis, the PG II levels were higher and the PG I/II ratios were lower than among those without H. pylori gastritis. A cut-off values of (i) PG I/II ≤ 5; (ii) PG II ≥ 10 or PG I/II ≤ 5; (iii) PG II ≥ 12 or PG I/II ≤ 4.5 showed high sensitivity and accuracy (over 90%) for diagnosing H. pylori-induced gastritis. Moreover, in a mass screening of healthy subjects, a cut-off value of PG I/II ≤ 4.5 might be better for diagnosing the presence of gastritis because of a sensitivity and specificity > 80%.
CONCLUSIONS: The presence of H. pylori-induced gastritis can be evaluated using serum PG levels.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Helicobacter pylori; gastritis; pepsinogen

Mesh:

Substances:

Year:  2015        PMID: 25974661     DOI: 10.1111/jgh.12987

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.

Authors:  Mariko Kiso; Masaharu Yoshihara; Masanori Ito; Kazuhiko Inoue; Katsuaki Kato; Shigemi Nakajima; Katsuhiro Mabe; Masao Kobayashi; Naomi Uemura; Tomoyuki Yada; Masashi Oka; Takashi Kawai; Tomoyuki Boda; Takahiro Kotachi; Kazuhiko Masuda; Shinji Tanaka; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2016-12-26       Impact factor: 7.370

2.  The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study.

Authors:  Toshihiro Ohtsu; Atsushi Takagi; Naomi Uemura; Kazuhiko Inoue; Hisakuni Sekino; Akihiro Kawashima; Masayuki Uchida; Yasuhiro Koga
Journal:  Digestion       Date:  2017-07-29       Impact factor: 3.216

3.  Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial.

Authors:  Atsushi Takagi; Hidetaka Yanagi; Hideki Ozawa; Naomi Uemura; Shigemi Nakajima; Kazuhiko Inoue; Takashi Kawai; Toshihiro Ohtsu; Yasuhiro Koga
Journal:  Gastroenterol Res Pract       Date:  2016-07-11       Impact factor: 2.260

4.  Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings.

Authors:  Sang Pyo Lee; Sun Young Lee; Jeong Hwan Kim; In Kyung Sung; Hyung Seok Park; Chan Sup Shim
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

5.  Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia.

Authors:  Muhammad Miftahussurur; Iswan Abbas Nusi; Fardah Akil; Ari Fahrial Syam; I Dewa Nyoman Wibawa; Yudith Annisa Ayu Rezkitha; Ummi Maimunah; Phawinee Subsomwong; Muhammad Luthfi Parewangi; I Ketut Mariadi; Pangestu Adi; Tomohisa Uchida; Herry Purbayu; Titong Sugihartono; Langgeng Agung Waskito; Hanik Badriyah Hidayati; Maria Inge Lusida; Yoshio Yamaoka
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

Review 6.  Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening.

Authors:  Xian-Zhe Chen; Cheng-Zhi Huang; Wei-Xian Hu; Ying Liu; Xue-Qing Yao
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

7.  HIV related hypochlorhydria does not appear to respond to anti-retroviral therapy in Zambian adults: a case control study.

Authors:  Violet Kayamba; Aaron Shibemba; Kanekwa Zyambo; Douglas Corbett Heimburger; Douglas Morgan; Paul Kelly
Journal:  Pan Afr Med J       Date:  2018-10-22

8.  Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens.

Authors:  Tadashi Shimoyama; Daisuke Chinda; Yoshihiko Sawada; Kazuo Komai; Hironobu Chiba; Yoshiharu Saito; Yoshio Sasaki; Masashi Matsuzaka; Shinsaku Fukuda
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

Review 9.  Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.

Authors:  Sun-Young Lee
Journal:  Korean J Intern Med       Date:  2016-09-01       Impact factor: 2.884

10.  Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection.

Authors:  Shogo Kikuchi; Mototsugu Kato; Katsuhiro Mabe; Takashi Kawai; Takahisa Furuta; Kazuhiko Inoue; Masanori Ito; Masaharu Yoshihara; Masaaki Kodama; Kazunari Murakami
Journal:  J Epidemiol       Date:  2018-09-22       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.